Women's Opioid Treatment Follow-up Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 8, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

November 30, 2025

Conditions
Opioid Use Disorder
Interventions
BEHAVIORAL

Gender-specific digital intervention (GSDI)

The GSDI is a digital intervention that incorporates factors that are more prevalent in women with opioid use disorder that may affect their treatment outcomes. The content for the intervention was derived from research on gender-specific substance use disorder antecedents, consequences, and treatment outcomes.

OTHER

Treatment as usual

Participants will receive treatment as usual for opioid use disorder which is a mix of medication treatment and individual and group therapy services across various levels of care.

Trial Locations (1)

02478-1064

McLean Hospital, Belmont

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Mclean Hospital

OTHER

NCT05776966 - Women's Opioid Treatment Follow-up Study | Biotech Hunter | Biotech Hunter